Related Experiment Video
Updated: Mar 20, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
995
Cancer risk in patients with recurrent or persistent symptoms: a systematic review
Faye Dannhauser1, Natalia Calanzani2, Aiman Aslam1,3
1Queen Mary University of London, Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Charterhouse Square, London, EC1M 6BT, UK.
The Lancet Regional Health. Europe
|March 19, 2026
Summary
Many cancer patients lack
Area of Science:
- Oncology
- General Practice
- Epidemiology
Background:
- Most cancer diagnoses follow symptomatic presentation.
- European guidelines prioritize 'alarm' symptoms for GP referrals.
- Approximately 50% of cancer patients do not exhibit 'alarm' symptoms.
Purpose of the Study:
- To systematically review and quantify the positive predictive values (PPVs) of recurrent and persistent symptoms for cancer diagnosis.
- To assess the cancer risk associated with non-'alarm' symptoms.
Main Methods:
- Systematic review of 21 studies.
- Inclusion of data from nearly 200,000 patients.
- Analysis of positive predictive values (PPVs) for 33 recurrent and 22 persistent symptoms.
Main Results:
- Definitions of 'persistent' and 'recurrent' symptoms were inconsistent across studies.
- Recurrent abdominal distension, abdominal pain, and rectal bleeding showed PPVs >3% in younger patients.
- Persistent symptoms were primarily studied in already referred patient populations.
Conclusions:
- Current referral guidelines may overlook significant cancer risk in patients with non-'alarm' symptoms.
- Clearer definitions for symptom recurrence and persistence are needed.
- Prospective validation of cancer risk for non-'alarm' symptoms across all age groups is crucial for improving early cancer diagnosis.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer Survival Analysis
812
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
812
Cancer Prevention
8.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.6K
Cancer Prevention
3.0K
3.0K
Treatment Resistent Cancers
1.5K
1.5K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
